Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(7%)
Results Posted
14%(1 trials)

Phase Distribution

Ph phase_3
2
13%
Ph phase_4
6
40%
Ph not_applicable
5
33%
Ph phase_2
2
13%

Phase Distribution

0

Early Stage

2

Mid Stage

8

Late Stage

Phase Distribution15 total trials
Phase 2Efficacy & side effects
2(13.3%)
Phase 3Large-scale testing
2(13.3%)
Phase 4Post-market surveillance
6(40.0%)
N/ANon-phased studies
5(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

15

all time

Status Distribution
Active(1)
Completed(7)
Terminated(2)
Other(5)

Detailed Status

Completed7
unknown5
Withdrawn2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (13.3%)
Phase 32 (13.3%)
Phase 46 (40.0%)
N/A5 (33.3%)

Trials by Status

completed747%
unknown533%
withdrawn213%
recruiting17%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials
NCT04606264Phase 3

Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data

Completed
NCT06382012Phase 2

Antiemetic Fosaprepitant To Remedy Nausea and Vomiting

Recruiting
NCT05475873Not Applicable

Ondansetron for Postspinal Anesthesia Hypotension

Completed
NCT05221151Phase 4

Melatonin vs Pregabalin for Anxiolysis and Sedation

Completed
NCT03182179Not Applicable

Efficacy of Ondansetron in LARS Treatment

Completed
NCT05127876Phase 4

Ephedrine Versus Ondansetron During Cesarean Delivery

Completed
NCT04983498Phase 4

Enhanced Recovery Pathway for Endoscopy

Withdrawn
NCT03117894Not Applicable

PECS-2 for Breast Surgery

Completed
NCT04318847Phase 4

Efficacy and Safety of the Administration of Ondansetron Versus Habitual Clinical Practice for the Treatment of Vomiting in Children With Mild and Moderate Dehydration: Randomized Clinical Trial

Unknown
NCT04703088Phase 3

ONDANSETRON AND EFFECTIVE DOSE IN 50% OF SUBJECTS OF PROPHYLACTIC NOREPINEPHRINE INFUSIONS FOR PREVENTING SPINAL ANESTHESIA-INDUCED HYPOTENSION DURING CESAREAN DELIVERY

Unknown
NCT04576390Phase 4

Palonosetron Versus Ondansetron for PONV Prevention in Patients Undergoing ERCP

Unknown
NCT03297021Phase 4

Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting

Completed
NCT04191694Not Applicable

Chewing Gum to Prevent Nausea and Vomiting After Caesarean Section Under Spinal Anaesthesia

Unknown
NCT03530007Phase 2

Anti-shivering Effect of Ondansetron

Unknown
NCT00699894Not Applicable

Aprepitant PO vs Ondansetron IV for Prevention of Postoperative Nausea and Vomiting

Withdrawn

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15